PLYX
Polaryx Therapeutics, Inc.
Nasdaq Pharmaceutical Preparations
Emerging growth company

Key Financials

Net Income
$-8985000
↑ 70.4%
Operating Income
$-7821000
↓ 79.7%
Total Assets
$5.2M
↑ 3.4%
EPS (Diluted)
$-0.20
↑ 77.5%
Total Liabilities
$605000.00
↑ 109.3%
Cash & Equivalents
$5.1M
↑ 11.3%
Shareholders' Equity
$4.6M
↓ 3.1%
Operating Cash Flow
$-3944000.00
↓ 53.3%

Recent SEC Filings

Form Type Filed Date Link
4 5/28/2026 View on SEC
8-K 5/28/2026 View on SEC
10-Q 5/15/2026 View on SEC
10-K 3/24/2026 View on SEC
4 2/20/2026 View on SEC
SCHEDULE 13D 2/5/2026 View on SEC
424B4 2/2/2026 View on SEC
EFFECT 1/29/2026 View on SEC
3 1/29/2026 View on SEC
3 1/29/2026 View on SEC

Company Information

Field Value
Ticker PLYX
Company Name Polaryx Therapeutics, Inc.
CIK 2075320
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation WY
Phone 201-940-7236